The Basel-based pharmaceutical company Myovant Sciences has published positive study results for its therapy relugolix, which has now been shown to be effective and safe…
Aurealis Pharma AG has closed a 5.6 million Swiss franc financing round. Headquartered in Basel and Finland, the biotechnology company develops medications for cancer and…
The Basel-based biotechnology company Cellestia has received approval for the first clinical trial on its compound CB-103. The clinical trial will be open to patients…
The Basel-based pharmaceutical company Roche has entered a cooperation agreement with the consultancy firm Accenture. The aim is to develop a data platform that connects…
With its acquisition of Aptuit, the biotechnology company Evotec intends to strengthen its position as a leading provider of drug research and development services. Aptuit,…
Each year some 250,000 patients develop a type of cancer because of faulty communication between cells. This malfunction occurs in what is known as the…
Kickstart Accelerator, an initiative by digitalswitzerland grows further and introduces a sixth vertical - EdTech. This vertical is introduced in partnership with EPFL and operated…
Roivant Sciences, a fast-growing life sciences company from the US, recently opened its global headquarters in Basel. In celebration of their newly established location, Roivant,…